The N4 research group are starting up several new clinical trials in the autumn and winter of 2022. We plan to provide a brief introduction to each project over the coming months, and will start with ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA. GRANDIOSA is a blinded, placebo-controlled, randomized clinical trial […]
Read More
We are happy to announce that over 7000 families are now part of the NorthPop study! We are also impressed by and grateful for the commitment shown by our participants during the corona pandemic, where interest in joining the study has remained high. Now over 20 000 individuals (mothers, partners and children) participate in this […]
Read More
The risk of developing asthma and eczema is higher in children treated with antibiotics in their first 18 months of life than in children who have not received antibiotics. This is shown by a study of roughly 1,300 families within the NorthPop cohort study. The study on antibiotic treatment and the risk of developing allergic […]
Read More